SAN DIEGO–Nanogen, Inc. (Nasdaq: NGEN), developer of in vitro diagnostic products, announced that on March 12, 2009 the company received a Staff Determination letter from NASDAQ (the “Delisting Notice”) indicating that the Company is subject to delisting proceedings due to non-payment of certain outstanding fees as required for continuing listing set forth in NASDAQ’s Marketplace […]
Mar 12, 2009, PLEASANTON, CA. Arcxis Biotechnologies, a privately held biomedical device firm, today announced a strategic partnership and technology development agreement with In-Q-Tel to accelerate availability of the Arcxis nucleic acid sample preparation platform and diagnostic consumable product line. In-Q-Tel is the independent strategic investment firm that identifies innovative technology solutions to support the […]
MUKILTEO, Wash., March 12, 2009 — CombiMatrix Corporation (NasdaqGM:CBMX – News) announced today that it has received a four year contract for $858,298 from NASA’s Ames Research Center to design and test a microfluidic system that incorporates CombiMatrix’s semiconductor microarray as part of an integrated genetic analysis platform that can be deployed in satellites. Funding […]
Physician Access to Critical Test Results Improved by More Than Twenty-Four Hours Over Conventional Methods SUNNYVALE, Calif., March 11 — Cepheid (Nasdaq: CPHD – News) today announced that Health Canada has issued a medical device license for its Xpert® MRSA/SA Blood Culture (BC) test for the rapid detection of Methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus […]
HOUSTON, March 10 — SeqWright, a world-wide leader in custom genomic and molecular biology services, announced today that it has been granted a California clinical laboratory license. This license enables SeqWright to utilize its DNA sequencing and Single Nucleotide Polymorphism (SNP) Genotyping expertise in order to provide genetic tests to California residents and represents a […]
Enzo Biochem, Inc. (NYSE: ENZ) today announced that its Enzo Clinical Labs subsidiary has strengthened its senior management team with the appointment of Kevin Krenitsky, M.D., as President. Krenitsky is a highly respected 12-year veteran of the life sciences industry, bringing a wealth of experience in building and managing global diagnostic operations. “Kevin’s impressive credentials […]
To mark International Women’s Day on March 8th, QIAGEN will provide human papillomavirus (HPV) testing products for the testing of underprivileged women at 29 hospitals across China. The free testing program is part of the larger “3.8 Program” – a nationwide prevention campaign organized by the Cancer Foundation of China and partially sponsored by QIAGEN. […]
OMAHA, Neb., March 5, 2009 — Transgenomic, Inc. (OTC BB: TBIO.OB), a leading global biotechnology company, announced today its Molecular Laboratory has received notification from the state of California it can begin offering its services in the state. Transgenomic expects to begin marketing their Molecular Laboratory services, including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology […]
Nanogen, Inc. (Nasdaq: NGEN), developer of molecular and rapid diagnostic products, announced today that it has signed an end user license agreement (EULA) with Quest Diagnostics for use of the Company’s proprietary MGB Probe technology in human in vitro diagnostic testing. Under the licensing agreement, Quest Diagnostics will have rights to use and sell products […]
Lab21 Ltd has today announced that it has purchased the majority shareholding of Biotec Laboratories Ltd, a clinical diagnostic company with particular emphasis on infectious diseases, most notably tuberculosis (TB). As part of the sale, Lab21 also acquires Biotec’s South African subsidiary, Biotec Laboratories SA which is a joint venture with the Cape Biotech Trust. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
